147
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The Impact of BCL11A Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females

ORCID Icon, , ORCID Icon &
Pages 311-325 | Published online: 07 Apr 2022

References

  • Cavusoglu M, Sozmen Ciliz D, Ozsoy A, et al. Diffusion-weighted MRI of postmenopausal women with vaginal bleeding and endometrial thickening: differentiation of benign and malignant lesions. J Belgian Soc Radiol. 2016;100(1):70. doi:10.5334/jbr-btr.1118
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
  • Li X, Zheng S, Chen S, Qin F, Lau S, Chen Q. Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Tumour Biol. 2015;36(7):4961–4966. doi:10.1007/s13277-015-3143-6
  • Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of endometrial cancer. Am Fam Physician. 2016;93(6):468–474.
  • Du Q, Guo X, Zhang X, et al. SYNJ2 variant rs9365723 is associated with colorectal cancer risk in Chinese Han population. Int J Biol Markers. 2016;31(2):e138–143. doi:10.5301/jbm.5000182
  • He N, Liu L, Duan X, et al. Identification of a shared protective genetic susceptibility locus for colorectal cancer and gastric cancer. Tumour Biol. 2016;37(2):2443–2448. doi:10.1007/s13277-015-4070-2
  • Jin TB, Du S, Zhu XK, et al. Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis: analyses of case-cohort studies. Medicine. 2016;95(31):e4231. doi:10.1097/MD.0000000000004231
  • Lazarus KA, Hadi F, Zambon E, et al. BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma. Nat Commun. 2018;9(1):3327. doi:10.1038/s41467-018-05790-5
  • Huang HT, Chen SM, Pan LB, Yao J, Ma HT. Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer. Oncol Rep. 2015;33(1):283–291. doi:10.3892/or.2014.3584
  • Zhu L, Pan R, Zhou D, Ye G, Tan W. BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer. Cancer Manag Res. 2019;11:2997–3007. doi:10.2147/CMAR.S199368
  • Park SY, Lee SJ, Cho HJ, et al. Epsilon-globin HBE1 enhances radiotherapy resistance by down-regulating BCL11A in colorectal cancer cells. Cancers. 2019;11(4):498. doi:10.3390/cancers11040498
  • You D, Lin L, Wang Q, et al. Clinical significance of BCL11A expression in ER-negative and PR-negative endometrial carcinoma. Int J Clin Exp Pathol. 2018;11(6):3068–3075.
  • Er TK, Su YF, Wu CC, et al. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. J Mol Med. 2016;94(7):835–847. doi:10.1007/s00109-016-1395-2
  • O’Mara TA, Spurdle AB, Glubb DM. Analysis of promoter-associated chromatin interactions reveals biologically relevant candidate target genes at endometrial cancer risk loci. Cancers. 2019;11(10). doi:10.3390/cancers11101440
  • O’Mara TA, Glubb DM, Amant F, et al. Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018;9(1):3166. doi:10.1038/s41467-018-05427-7
  • Oeth P, Del Mistro G, Marnellos G, Shi T, van den Boom D. Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY). Methods Mol Biol. 2009;578:307–343.
  • Ellis JA, Ong B. The MassARRAY((R)) system for targeted SNP genotyping. Methods Mol Biol. 2017;1492:77–94.
  • Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434–442. doi:10.1093/jnci/djh075
  • Zhuo Z, Lu H, Zhu J, et al. METTL14 gene polymorphisms confer neuroblastoma susceptibility: an eight-center case-control study. Mol Ther Nucleic Acids. 2020;22:17–26. doi:10.1016/j.omtn.2020.08.009
  • Weniger MA, Pulford K, Gesk S, et al. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia. 2006;20(10):1880–1882. doi:10.1038/sj.leu.2404324
  • Chen Z, Luo HY, Steinberg MH, Chui DH. BCL11A represses HBG transcription in K562 cells. Blood Cells Mol Dis. 2009;42(2):144–149. doi:10.1016/j.bcmd.2008.12.003
  • Yin B, Delwel R, Valk PJ, et al. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood. 2009;113(5):1075–1085. doi:10.1182/blood-2008-03-144436
  • Yu Y, Wang J, Khaled W, et al. Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med. 2012;209(13):2467–2483. doi:10.1084/jem.20121846
  • Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control. 2011;22(6):877–883. doi:10.1007/s10552-011-9760-5
  • Zhou J, Yang Y, Zhang D, Zhou L, Tao L, Lu LM. Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma. PLoS One. 2017;12(2):e0171116. doi:10.1371/journal.pone.0171116
  • Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood. 2007;109(3):1202–1210. doi:10.1182/blood-2006-07-034256
  • Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930–934. doi:10.1093/nar/gkr917
  • Neishabury M, Zamani F, Keyhani E, et al. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background. Blood Cells Mol Dis. 2013;51(2):80–84. doi:10.1016/j.bcmd.2013.02.007
  • Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342(6155):253–257. doi:10.1126/science.1242088
  • Zhou JY, Zhang L, Wei LH, Wang JL. Endometrial carcinoma-related genetic factors: application to research and clinical practice in China. BJOG. 2016;123(Suppl 3):90–96. doi:10.1111/1471-0528.14007
  • Nitecki R, Fu S, Lefkowits C, et al. Employment disruption following the diagnosis of endometrial cancer. Gynecol Oncol. 2021;160(1):199–205. doi:10.1016/j.ygyno.2020.10.041
  • Shaw E, Farris M, McNeil J, Friedenreich C. Obesity and endometrial cancer. Recent Results Cancer Res. 2016;208:107–136. doi:10.1007/978-3-319-42542-9_7
  • Niu T, Qin ZS, Xu X, Liu JS. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet. 2002;70(1):157–169. doi:10.1086/338446
  • Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19(3):376–382. doi:10.1093/bioinformatics/btf869